Who owns NEUROONE MED TECHNOLOGIES CORP COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Neuroone Med Technologies Corp with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Neuroone Med Technologies Corp stock

Who bought or sold NEUROONE MED TECHNOLOGIES CORP COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Nantahala Capital Management 1.2M $1.4M -1% Mar 2024
 View chart
Vanguard Group 919k $1.1M 0% Mar 2024
 View chart
Geode Capital Management 222k $266k 25% Mar 2024
 View chart
Mayo Clinic 182k $218k 0% Mar 2024
 View chart
Perkins Capital Management 150k $180k 0% Mar 2024
 View chart
MAI Wealth Advisors 50k $60k 0% Mar 2024
 View chart
Northern Trust 30k $36k 52% Mar 2024
 View chart
Princeton Global Asset Management 17k $20k 0% Mar 2024
 View chart
Two Sigma Securities 11k $14k 100% Mar 2024
 View chart
Tower Research Capital 7.0k $8.4k 100% Mar 2024
 View chart
Centerpoint Advisors 5.0k $6.0k 0% Mar 2024
 View chart
Simplex Trading 1.7k $2.0k -41% Mar 2024
 View chart
Nemes Rush Group 433.00 $519.989700 0% Mar 2024
 View chart
Advisor Group Holdings 350.00 $420.000000 0% Mar 2024
 View chart
Wells Fargo & Company 193.00 $232.005300 10% Mar 2024
 View chart
UBS Group 108.00 $129.999600 -94% Mar 2024
 View chart
Jpmorgan Chase & Co 55.00 $66.000000 41% Mar 2024
 View chart

Who sold out of Neuroone Med Technologies Corp?

Fund or Company Name Date Sold Shares Held Valued At
Wealth Alliance Advisory Group Dec 2023 20k $31k
Virtu Financial Dec 2023 18k $29k
Citadel Advisors Dec 2023 15k $24k
Goss Wealth Management Sep 2023 2.4k $2.1k